Implantable Cardioverter Defibrillator (ICD)

This channel includes news and new technology innovations for implantable cardioverter defibrillators (ICD) used to treat tachycardia arrhythmias and heart failure. This includes cardiac resynchronization therapy defibrillators (CRT-D).

In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.
Feature | Telecardiology | Victor Wollesen

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

Home July 23, 2021
Home
News | EP Lab

June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...

Home June 02, 2021
Home
News | EP Lab

May 14, 2021 — The U.S. Food and Drug Administration (FDA) is advising patients and caregivers to keep any consumer ...

Home May 14, 2021
Home
News | EP Lab

April 26, 2021 — Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for ...

Home April 26, 2021
Home
Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.
Feature | EP Lab

April 12, 2021 — Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac ...

Home April 12, 2021
Home
News | EP Lab

April 2, 2021 — Today, the American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant ...

Home April 02, 2021
Home
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.
Feature | EP Lab | By Maninder Bedi, M.D.

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

Home March 17, 2021
Home
Figure 1: Picture of the Emblem S-ICD Subcutaneous Electrode with an arrow showing where separation usually happens (distal to the proximal sense ring).
Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...

Home February 02, 2021
Home
News | EP Lab

February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current ...

Home February 02, 2021
Home
Feature | By Dave Fornell, Editor

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home February 01, 2021
Home
News | Implantable Cardioverter Defibrillator (ICD)

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...

Home January 08, 2021
Home
Videos | EP Device Monitoring Systems

Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has ...

Home December 22, 2020
Home
Chest X-ray, posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.
Feature | Magnetic Resonance Imaging (MRI)

October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR ...

Home October 27, 2020
Home
News | EP Lab

September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...

Home September 08, 2020
Home
News | EP Lab

July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable ...

Home July 13, 2020
Home
Subscribe Now